Beijing Boya United Pharmaceutical Research Institute

Beijing Boya United Pharmaceutical Research Institute is a Chinese biotechnology research organization dedicated to the development of innovative therapeutics and modernized traditional medicines. Established in 1998, the institute has built a portfolio focused primarily on metabolic disorders, cardiovascular health, and oncology. It is well-regarded for its work on insulin analogs and recombinant protein technologies, aiming to provide affordable and effective treatments for the Chinese market. The institute provides a range of services including drug synthesis, pharmacological testing, and clinical trial coordination. By integrating modern molecular biology with traditional pharmacological insights, Boya United continues to advance its pipeline of small molecules and biologics.